Clinical trial
A Study of Different Doses of Atevirdine Mesylate Plus Zidovudine in…
NCT00002322 · Pharmacia and Upjohn, Industry · Completed
Key facts
| NCT number | NCT00002322 |
|---|---|
| Title | A Study of Different Doses of Atevirdine Mesylate Plus Zidovudine in HIV-Positive Patients |
| Official title | Randomized, Double-Blind, Placebo-Controlled Comparative Dose-Response Study of Two Doses of Atevirdine Mesylate (U-87201E) in Combination With Fixed Doses of Zidovudine (AZT) in HIV+ Patients |
| Lead sponsor | Pharmacia and Upjohn, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Atevirdine mesylate, Zidovudine |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: